Zobrazeno 1 - 10
of 112
pro vyhledávání: '"Dae Woon Eom"'
Autor:
Soo Yong Choi, Jong Kyu Park, Sang Jin Lee, Woo Jin Jung, Hak Soo Kim, Gab Jin Cheon, Dae Woon Eom
Publikováno v:
The Korean Journal of Helicobacter and Upper Gastrointestinal Research, Vol 17, Iss 4, Pp 213-217 (2017)
Although gastric hyperplastic polyps are recognized as benign lesions, there is concern regarding carcinomatous changes in the polyps, depending on their size. If the polyp size is larger than 1.0∼2.0 cm, endoscopic resection is usually recommended
Externí odkaz:
https://doaj.org/article/0994d4293cfb44ff88c1dcab4dcf0bd2
Autor:
Min Sik Hwang, Young Don Kim, Sa Young Shin, Jae Hyuck Jun, Jong Sam Hong, Dae Woon Eom, Gab Jin Cheon
Publikováno v:
The Korean Journal of Gastroenterology, Vol 68, Iss 4, Pp 214-217 (2016)
Endometriosis is a benign gynecologic disease, characterized by the presence and growth of functional endometrial-like tissue outside uterus. This ectopic endometrial tissue is most commonly found in the peritoneum, ovaries and uterosacral ligaments,
Externí odkaz:
https://doaj.org/article/adfb8798054744399bc755fc31df95de
Autor:
Man Ho Lee, Dae Shick Ryu, Dae Woon Eom, Dong Rock Shin, Soo-Jung Choi, Jae Hong Ahn, Man Soo Park, Dong Kon Yoo
Publikováno v:
대한영상의학회지, Vol 72, Iss 3, Pp 189-192 (2015)
Esophageal schwannomas are a relative rare benign neoplasm that usually occurs in the upper esophagus, in the middle aged women. We report a case of a 67-year-old man with a lower esophageal schwannoma. This lesion was composed of homogenous density,
Externí odkaz:
https://doaj.org/article/dd29e6fe103c4c789aa0f05c9cc8e39b
Autor:
Wook Nam, Han Kyu Chae, Yeonuk Jung, Homin Kang, Myungchan Park, Ahnryul Choi, Jong Yeon Park, Dae-Woon Eom, Sung Jin Kim
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionPredicting the response to Bacillus Calmette–Guérin (BCG) therapy in high-risk patients with non-muscle invasive bladder cancer (NMIBC) is crucial, as failure may necessitate interventions, such as radical cystectomy or salvage therapy
Externí odkaz:
https://doaj.org/article/0e95adc38d8845939cea90c0610651fc
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Colorectal adenocarcinoma is the third most common cancer worldwide and a leading cause of cancer-related death. The recent emergence of diverse immunotherapeutic agents has made it crucial to interpret a complex tumour microenvir
Externí odkaz:
https://doaj.org/article/1e94c221517a4391947db555928ce37e
Autor:
So Won Kim, Hoon Yu, Younjuong Kim, Kyeng Hyun Nam, Han Kyu Chae, Wook Nam, Dae-Woon Eom, Jong Yeon Park, Sung Jin Kim
Publikováno v:
International Journal of Surgery; Feb2024, Vol. 110 Issue 2, p847-858, 12p
Publikováno v:
Oncology letters. 24(4)
Indoleamine 2, 3-dioxygenase 1 (IDO1) is an immunomodulatory enzyme that catalyzes the degradation of tryptophan to kynurenine and induces immune tolerance in tumor cells. The effects of IDO1 on extrahepatic bile duct carcinoma (EHBDC) are poorly und
Autor:
Han Kyu Chae, Wook Nam, Han Gwun Kim, Sharon Lim, Byeong-Joo Noh, So Won Kim, Gil Hyun Kang, Jong Yeon Park, Dae-Woon Eom, Sung Jin Kim
Publikováno v:
Frontiers in Immunology. 13
Bacillus Calmette–Guérin (BCG) is the gold standard adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC). However, given the current global shortage of BCG, new treatments are needed. We evaluated tumor microenvironment markers as pot
Autor:
Byeong-Joo, Noh, Gun Moo, Choi, Hyuk Jai, Jang, Chung Hyeun, Ma, Ho-Suk, Oh, Moonho, Kim, Dae-Woon, Eom
Publikováno v:
Annals of clinical and laboratory science. 52(2)
Pancreatic ductal adenocarcinoma (PDAC) and extrahepatic bile duct carcinoma (EBDC) are distinct entities with different clinicopathological implications. Therefore, research to differentiate between the two diseases is compulsory. In this study, fou
Publikováno v:
Pathology. 52:228-235
The diagnosis of small intestinal adenocarcinoma (SIAC) is usually determined at an advanced stage due to non-specific symptoms and the difficulty of exploring the small intestine. Therefore, the majority of SIAC patients have limited chemotherapeuti